Aethlon Medical, Inc. AEMD 深 沪
等待开盘 02-18 09:30:00 美东时间
2.12
+0.160
+8.16%
华盛通- 最 高2.19
- 今 开1.99
- 成交量 8.59万股
- 最 低 1.95
- 昨 收 1.96
- 总市值 206.32万
- 52周最高 47.92
- 市盈率 静 --
- 换手率 8.83%
- 52周最低 1.8575
- 委 比 -75.44%
- 总股本 97.32万
- 历史最高 432000.00
- 量 比 2.45
- 振 幅 12.24%
- 历史最低 1.8575
- 每 手 1
- 风险率 12.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aethlon Medical signals faster clinical trial enrollment amid Hemopurifier advancements
Earnings Call Insights: Aethlon Medical (AEMD) Q3 2026 Management View James Frakes, CEO and CFO, stated that Aethlon Medical continues to execute its strategy of advancing the Hemopurifier platform w...
02-13 11:15
Earnings Scheduled For February 12, 2026
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
Aethlon Medical Files For Common Stock Offering Of $15M
$15,000,000 Common Stock From time to time, we may offer and sell shares of our common stock, par value $0.001 per share, with total gross proceeds of up to $15,000,000. This prospectus provides a general
2025-12-24 04:10
Aethlon Medical Announces Publication Of Pre-Clinical Long COVID Study On bioRxiv
Results Support the Further Investigation of the Hemopurifier in Long COVIDSAN DIEGO, Dec. 2, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to
2025-12-02 21:26
Aethlon Medical Reports Hemopurifier Removes Inflammatory Extracellular Vesicles in Long COVID Study
Aethlon Medical Inc. has announced the publication of preclinical data demonstrating that the GNA affinity resin in its Hemopurifier® device binds to extracellular vesicles (EVs) in plasma samples fro...
2025-12-02 21:02
Aethlon Medical shares are trading higher. The company reported Q2 financial results.
Aethlon Medical shares are trading higher. The company reported Q2 financial re...
2025-11-13 22:15
Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(3.74) per share which missed the analyst consensus estimate of $(3.66) by 2.1 percent. This is a 133.75 percent decrease over losses of $(1.60) per share from
2025-11-13 05:16
Aethlon Medical Inc. to Report Fiscal Second Quarter Results
Aethlon Medical Inc. will release its fiscal second quarter financial results on November 12, 2025. The results will be issued at 4:15 p.m. ET. A conference call to review the results and recent corpo...
2025-11-07 21:01
Aethlon Medical Regains Nasdaq Compliance
On November 5, 2025, Aethlon Medical, Inc., a Nevada corporation (the "Company") received a letter from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it
2025-11-06 22:22
